Eli Lilly enters $1 billion agreement to acquire Prevail Therapeutics
Eli Lilly & Co and Prevail Therapeutics announced a definitive agreement for Lilly to acquire Prevail for a total consideration
Read moreEli Lilly & Co and Prevail Therapeutics announced a definitive agreement for Lilly to acquire Prevail for a total consideration
Read morePharmaBlock Sciences, a pioneering service provider throughout the pharmaceutical R&D processes, announced it has entered into a strategic partnership with
Read moreModerna announced today that the European Commission has approved an agreement to buy 80 million doses of mRNA-1273, Moderna’s COVID-19
Read morePfizer and BioNTech announced this week that they have reached an agreement with the European Commission to supply 200 million
Read moreSanofi and GSK plan to make available to the Gavi lead COVAX Facility 200 million doses of their adjuvanted recombinant
Read moreEli Lilly and Company officially announced on Oct. 28, an initial deal with the U.S. government to supply 300,000 vials
Read moreBristol Myers Squibb is strengthening its cardiovascular pipeline through a $13.1 Billion acquisition of biotech firm MyoKardia. The $13.1 Billion
Read moreNestlé’s nutritional science brand Nestlé Health Science (NHSc) furthers efforts of food allergy prevention through the acquisition of California-based biopharmaceutical
Read moreSanofi and GlaxoSmithKline are close to reaching a 500 million-pound ($624 million) deal to supply the United Kingdom government with
Read moreModerna, a clinical-stage biotech developing messenger RNA (mRNA) therapeutics and vaccines, and Swiss pharma giant Lonza today announced the introduction
Read more